HIF1A and cancer: PKM2 is highly expressed in tumor cells and has been shown to promote late pro-inflammatory cytokines though its interaction with hypoxiainducible factor 1α (HIF-1α) [52], and has a role as a critical mediator in inflammatory microenvironment of cancer [53, 54].